Thymulin
Research OnlyA zinc-dependent nonapeptide hormone produced by thymic epithelial cells, discovered in 1977. Requires zinc binding for biological activity and plays a role in T-cell differentiation and immune regulation. While well-characterized biochemically, therapeutic development has been limited compared to other thymic peptides like thymosin alpha-1.
FTS · Facteur Thymique Serique · Serum Thymic Factor · Thymulin Zinc Complex
8 human studies
- Preclinical
- 82%
- Human research
- 18%
Based on 45 cited sources
Numeric assessment unreviewed
A historical numeric score is recorded but has not passed a current, compound-specific assessment review. No numeric score is displayed.
This is a limitation of the numeric assessment, not a measured absence of benefit. It does not re-review the separately recorded catalogue classification or establish efficacy or safety.
The proposed mechanisms of thymulin are based primarily on animal, in vitro, and limited human observational studies. Thymulin is unique among thymic hormones in requiring zinc for biological activity.
How It Works (Simplified)
Thymulin functions as a zinc-dependent immune modulator through several pathways:
Requires 1:1 zinc binding for biological activity. The zinc ion binds to serine and asparagine residues, creating the active metallopeptide conformation.
Promotes thymocyte maturation and CD4+/CD8+ differentiation. Enhances T-cell and NK cell function in thymus-deficient models.
Modulates IL-2, IFN-gamma, TNF-alpha, and IL-6 production. Reduces p38 MAPK phosphorylation and microglial activation in inflammatory states.
Interacts with hypothalamic-pituitary axis. Demonstrates bidirectional immune-neural communication and stress response integration.
Key Research: Gastinel, Dardenne and colleagues demonstrated that thymulin binds a single zinc ion (1:1), with metal-binding potency correlating with its biological activity. PMID:6538097
Important Limitations
- Most therapeutic studies use thymulin analogs (PAT), not native thymulin
- Zinc status must be adequate for any thymulin effect
- Clinical efficacy trials are essentially absent
- Thymosin alpha-1 has far more clinical development and regulatory approvals
- Research activity has declined significantly since the 1990s
Based on preclinical observations: Zinc-dependent activation occurs rapidly upon administration. Animal studies show early effects on T-cell markers within days. No human timeline data available for exogenous thymulin administration.
PMID:6538097Animal studies suggest ongoing immune modulation effects. In zinc supplementation studies, restoration of thymulin activity observed within this timeframe. Analgesic effects in animal pain models noted within days to weeks.
PMID:3262625Preclinical models show continued immune regulatory effects. Aged-animal zinc supplementation studies demonstrated sustained thymulin activity restoration over several weeks. Long-term effects on immune parameters observed.
PMID:8582782Long-term animal and observational human studies suggest sustained effects when zinc status is maintained. However, human pharmacokinetics for exogenous thymulin, duration of effect, and optimal treatment protocols are completely unknown.
Research-based observations
This timeline reflects observations from published clinical and preclinical studies. Individual responses may vary significantly. This is not a guarantee of effects or a dosing schedule. Consult qualified healthcare providers for personalized guidance.
Thymosin-Alpha-1
SynergisticBoth thymic peptides with complementary mechanisms. Thymosin alpha-1 has more clinical development and regulatory approvals. Thymulin's zinc-dependent activity may complement thymosin alpha-1's direct immune modulation. No direct clinical studies on combination.
Thymalin
SynergisticBoth derived from thymic tissue with overlapping immune modulatory effects. Thymalin is a bovine thymic extract while thymulin is a defined nonapeptide. May have additive effects on T-cell function.
Zinc-Supplements
SynergisticZinc is absolutely required for thymulin biological activity. Zinc deficiency abolishes thymulin function. Adequate zinc status is essential for any thymulin effect.
Thymogen
CompatibleBoth target T-cell differentiation through thymic pathways. Thymogen (L-Glu-L-Trp dipeptide) has a simpler structure. No known contraindications; theoretical complementary benefits.
BPC-157
CompatibleNon-overlapping mechanisms. Thymulin modulates immune function while BPC-157 focuses on tissue repair. Theoretical complementary benefits for immune-mediated recovery.
LL-37
CompatibleLL-37's antimicrobial and immunomodulatory properties may complement thymulin's T-cell modulatory effects. Both influence immune function through distinct pathways.
Research Note: Interaction data is based on published literature, mechanistic understanding, and theoretical considerations. Most peptide combinations lack direct clinical study. This information is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare providers.
Key Studies Cited
Use the source links in the research discussion above to inspect the referenced records.
This dossier synthesizes available evidence from peer-reviewed literature, regulatory documents, and clinical trial registries. Evidence strength labels summarize the cited material for this entry and should be read alongside its population, model, and study limitations.
For complete methodology details, see our Methodology page.
Important Disclaimer
This dossier is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.
Get Research Alerts
New dossiers and major study summaries delivered to your inbox. Evidence-graded, citation-backed research you can trust.
No spam. Unsubscribe anytime.
Compare Thymulin
Related Peptides
Alpha-Defensins
HNP-1 · HNP-2 · HNP-3 +5
A family of small cationic antimicrobial peptides (29-35 amino acids) that are key components of innate immunity in humans. Produced primarily by neutrophils (HNP-1 to 4) and Paneth cells (HD-5, HD-6), they exhibit broad-spectrum antimicrobial activity and immunomodulatory functions. Well-characterized biochemically with extensive research, though therapeutic development faces challenges.
KPV
Lys-Pro-Val · Lysine-Proline-Valine · alpha-MSH(11-13) +1
Lys-Pro-Val is the C-terminal tripeptide motif of alpha-MSH. KPV reduced inflammatory readouts in cell and mouse colitis models, including a PepT1 uptake study. Human drug exposure, pharmacokinetics, safety and clinical benefit remain unestablished.
Kristagen
EDG · Glu-Asp-Gly · Immune tripeptide
A synthetic tripeptide (Glu-Asp-Gly) developed by Russian scientist Vladimir Khavinson, claimed to regulate thymus function and support immune cell differentiation. No Western clinical validation exists; research is limited to Russian preclinical studies.
Lactoferricin
LFcinB · Lactoferricin B · LfcinB +1
An antimicrobial peptide derived from lactoferrin, a protein found in milk and other secretions. Shows broad-spectrum antimicrobial activity in laboratory studies. Research focuses on potential applications in infectious disease, food safety, and cancer. Primarily studied preclinically with very limited human clinical data. Not approved as a therapeutic by any regulatory agency.
LL-37
LL37 · Human cathelicidin antimicrobial peptide LL-37
LL-37 is the active human cathelicidin peptide. Three topical wound trials studied native LL-37, with mixed outcomes; an oral trial used engineered bacteria expressing LL-37. These results do not establish systemic benefit.
Murepavadin
POL7080 · RG7929
A first-in-class cyclic antimicrobial peptide targeting the LptD outer membrane protein of Pseudomonas aeruginosa. The first OMPTA (outer membrane protein targeting antibiotic) to reach clinical development. IV formulation discontinued due to nephrotoxicity; inhaled formulation continues Phase 3 development for cystic fibrosis and bronchiectasis patients.
Compared With
3 comparisonsConditions Studied
3 entries- Thymulin for Immune Dysfunction Thymulin has been studied for its role in T-cell differentiation and immune regulation. Early research by Bach and colleagues esta…
- Thymulin for Zinc Deficiency Zinc is absolutely required for thymulin biological activity. Studies by Prasad and Mocchegiani demonstrated that zinc deficiency…
- Thymulin for Inflammatory Pain Preclinical studies have examined thymulin and its analog PAT for analgesic effects. Research from Safieh-Garabedian's group demon…